Item request has been placed!
×
Item request cannot be made.
×
Processing Request
68 Ga/ 177 Lu-Labeled Theranostic Pair for Targeting Fibroblast Activation Protein with Improved Tumor Uptake and Retention.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
- Publication Information:
Publication: Washington Dc : American Chemical Society
Original Publication: [Easton, Pa.] : American Chemical Society, [c1963-
- Subject Terms:
- Abstract:
Fibroblast activation protein (FAP) is specifically expressed on cancer-associated fibroblasts in over 90% of tumors and is considered a promising target for cancer theranostics. Here, we developed a novel tracer, DOTA-FAPT, and labeled it with gallium-68 and lutetium-177 as a theranostic pair. [ 68 Ga]Ga/[ 177 Lu]Lu-FAPT exhibited high stability and hydrophilicity, as well as strong affinity to the FAP target. Micro-PET/CT imaging revealed that [ 68 Ga]Ga-FAPT exhibited significantly increased uptake in tumors and extended retention in A549-FAP and U87MG tumor xenografts as compared to [ 68 Ga]Ga-FAPI-04, demonstrating favorable pharmacokinetic characteristics in vivo. Therapeutic studies showed that [ 177 Lu]Lu-FAPT had higher tumor accumulation compared to [ 177 Lu]Lu-FAPI-04, leading to stronger tumor growth inhibition. The first-in-human evaluation also revealed that [ 68 Ga]Ga-FAPT has good in vivo distribution and superior diagnostic efficacy on primary and lymph node metastases in a patient with lung cancer. Our encouraging results suggest that 68 Ga/ 177 Lu-labeled DOTA-FAPT is a theranostic pair with broad application prospect.
- Accession Number:
0 (Gallium Radioisotopes)
5H0DOZ21UJ (Lutetium)
98B30EPP5S (Gallium-68)
EC 3.4.21.- (fibroblast activation protein alpha)
0 (Radioisotopes)
BRH40Y9V1Q (Lutetium-177)
0 (Membrane Proteins)
EC 3.4.- (Endopeptidases)
0 (Radiopharmaceuticals)
EC 3.4.21.- (Serine Endopeptidases)
EC 3.4.24.- (Gelatinases)
0 (Heterocyclic Compounds, 1-Ring)
1HTE449DGZ (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid)
- Publication Date:
Date Created: 20240925 Date Completed: 20241010 Latest Revision: 20241010
- Publication Date:
20241010
- Accession Number:
10.1021/acs.jmedchem.4c01812
- Accession Number:
39321030
No Comments.